Literature DB >> 13868372

Effect of L-tryptophan on diuresis and 5-hydroxyindoleacetic acid excretion in the rat.

G BERTACCINI, M B NOBILI.   

Abstract

Oral administration of L-tryptophan to rats produced two main biochemical and pharmacological effects: a marked increase in urinary 5-hydroxyindoleacetic acid excretion, and a significant reduction in the urine flow after a water load. Urinary 5-hydroxyindoleacetic acid excretion reached its maximum 2 to 6 hr after the administration of tryptophan, and it increased with the dose of the amino acid. Antidiuresis was seen after the administration of L-tryptophan, 200 mg/kg, or more. The effect appeared promptly and it was roughly proportional to the dose of the amino acid administered. Both antidiuretic effect and increase in urinary 5-hydroxyindoleacetic acid excretion were more intense after oral than after parenteral administration of L-tryptophan. D-Tryptophan, in oral doses up to 1,000 mg/kg, produced neither an increase in urinary 5-hydroxyindoleacetic acid nor a reduction of diuresis. Available evidence suggests that reduction of urine flow is a consequence of biosynthesis and release of 5-hydroxytryptamine by the gastrointestinal mucosa. Tryptamine produced by direct decarboxylation of L-tryptophan does not seem to play any important role.

Entities:  

Keywords:  INDOLACETIC ACID/related compounds; KIDNEY/pharmacology; TRYPTOPHAN/pharmacology

Mesh:

Substances:

Year:  1961        PMID: 13868372      PMCID: PMC1482098          DOI: 10.1111/j.1476-5381.1961.tb01138.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN: 0366-0826


  7 in total

1.  Observations on the fate of indolalkylamines in the organism.

Authors:  V ERSPAMER
Journal:  J Physiol       Date:  1955-01-28       Impact factor: 5.182

2.  Observations on the release and turnover rate of 5-hydroxytryptamine in the gastrointestinal tract.

Authors:  V ERSPAMER; A TESTINI
Journal:  J Pharm Pharmacol       Date:  1959-10       Impact factor: 3.765

3.  Tryptophan loading and excretion of 5-hydroxyindoleacetic acid in normal and schizophrenic subjects.

Authors:  I J KOPIN
Journal:  Science       Date:  1959-03-27       Impact factor: 47.728

4.  Observations of schizophrenic patients after iproniazid and tryptophan.

Authors:  J W LAUER; W M INSKIP; J BERNSOHN; E A ZELLER
Journal:  AMA Arch Neurol Psychiatry       Date:  1958-07

5.  Endocrine aspects of argentaffinoma, with special reference to the use of urinary 5-hydroxyindoleacetic acid estimations in diagnosis.

Authors:  P S MACFARLANE; C E DALGLIESH; R W DUTTON; B LENNOX; L M NYHUS; A N SMITH
Journal:  Scott Med J       Date:  1956-04       Impact factor: 0.729

6.  Pharmacology of indole-alkylamines.

Authors:  V ERSPAMER
Journal:  Pharmacol Rev       Date:  1954-12       Impact factor: 25.468

7.  Tissue 5-hydroxytryptamine and urinary 5-hydroxyindoleacetic acid after partial or total removal of the gastro-intestinal tract in the rat.

Authors:  G Bertaccini
Journal:  J Physiol       Date:  1960-09       Impact factor: 5.182

  7 in total
  1 in total

Review 1.  Biological Effects of Indole-3-Propionic Acid, a Gut Microbiota-Derived Metabolite, and Its Precursor Tryptophan in Mammals' Health and Disease.

Authors:  Piotr Konopelski; Izabella Mogilnicka
Journal:  Int J Mol Sci       Date:  2022-01-22       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.